Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://www.ncbi.nlm.nih.gov/pubmed/8698630
http://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://www.ncbi.nlm.nih.gov/pubmed/8698630
http://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x

Ejemplares similares